Bosh sahifa068270 • KRX
add
Celltrion Inc
Yopilish kursi
160 300,00 ₩
Kunlik diapazon
159 400,00 ₩ - 161 000,00 ₩
Yillik diapazon
152 666,67 ₩ - 200 952,39 ₩
Bozor kapitalizatsiyasi
35,54 trln KRW
Oʻrtacha hajm
432,14 ming
Narx/foyda
77,83
Dividend daromadliligi
0,45%
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,06 trln | 178,01% |
Joriy xarajat | 347,40 mlrd | 182,95% |
Sof foyda | 236,65 mlrd | 22 354,46% |
Sof foyda marjasi | 22,25 | 7 846,43% |
Har bir ulushga tushum | 1,15 ming | 13 270,00% |
EBITDA | 275,17 mlrd | 201,50% |
Amaldagi soliq stavkasi | 14,02% | — |
Balans
Jami aktivlari
Jami passivlari
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,14 trln | 50,90% |
Jami aktivlari | 21,06 trln | 5,50% |
Jami passivlari | 3,48 trln | 22,75% |
Umumiy kapital | 17,58 trln | — |
Tarqatilgan aksiyalar | 215,26 mln | — |
Narxi/balansdagi bahosi | 1,98 | — |
Aktivlardan daromad | 2,37% | — |
Kapitaldan daromad | 2,52% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (KRW) | dek, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 236,65 mlrd | 22 354,46% |
Operatsiyalardan naqd pul | 305,93 mlrd | 104,51% |
Sarmoyadan naqd pul | -101,50 mlrd | -175,12% |
Moliyadan naqd pul | -228,94 mlrd | -214,96% |
Naqd pulning sof oʻzgarishi | 23,77 mlrd | -88,30% |
Boʻsh pul | 61,13 mlrd | 103,98% |
Haqida
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Tashkil etilgan
2002
Sayt
Xodimlar soni
1 074
